FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
ORTHODONTIX INC [ ORTX ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 12/31/2006 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 12/31/2006 | A | 2,886,447(1) | A | (1) | 2,886,447 | I | By Partnership |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Options (Right to Buy) | $0.001 | 12/31/2006 | A | 1,616,100 | (2) | 03/16/2010 | Common Stock | 1,616,100 | (3) | 1,616,100 | I | By Partnership | |||
Stock Options (Right to Buy) | $0.001 | 12/31/2006 | A | 1,768,402 | (4) | 03/16/2010 | Common Stock | 1,768,402 | (5) | 3,384,502 | I | By Partnership |
Explanation of Responses: |
1. Received in exchange for 47,256 ordinary shares of Protalix Ltd. (Protalix) in connection with the merger (the Merger) of Protalix into a wholly-owned subsidiary of Orthodontix, Inc. (Orthodontix). The shares acquired consist of 1,378,278 shares of Common Stock held by Pontifax (Cayman) L.P. and 1,508,169 of Common Stock held by Pontifax (Israel) L.P. Mr. Hurvitz disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. |
2. All shares of Common Stock underlying the options have vested prior to the date of the transaction. |
3. Received in connection with the Merger in exchange for options to acquire 26,710 ordinary shares of Protalix. 771,688 of the shares of Common Stock underlying the options are held by Pontifax (Cayman) L.P., and 844,412 of the shares of Common Stock underlying the options are held by Pontifax (Israel) L.P. Mr. Hurvitz disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. |
4. 50% of the options vested on January 1, 2007, and an additional 10% of the options will vest at the end of each three-month period thereafter. |
5. Received in connection with the Merger in exchange for options to acquire 28,700 ordinary shares of Protalix. 844,412 of the shares of Common Stock underlying the options are held by Pontifax (Cayman) L.P., and 923,990 of the shares of Common Stock underlying the options are held by Pontifax (Israel) L.P. Mr. Hurvitz disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. |
David Aviezer, Power of Attorney | 01/04/2007 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |